Zusammenfassung
Die wichtigen Parameter bei der Entwicklung der Thrombose werden bei einem Patienten mit Polyarteriitis nodosa und hochgradiger Innenohrschwerhörigkeit untersucht. Während der akuten Phase bestand eine Hyperaggregation der Thrombozyten, eine verminderte Lebenszeit der Thrombozyten sowie eine verminderte fibrinolytische Aktivität. Möglicherweise sind die beobachteten akustischen und vestibulären Störungen bei diesem Patienten Folge eines thromboembolischen Geschehens im Innenohr.
Summary
Parameters of importance for the development of thrombosis were investigated in a patient with polyarteritis nodosa (PAN) and profound sensorineural hearing loss. During the acute phase, platelet hyperaggregability, shortened platelet survival, and decreased fibrinolytic activity were found. The possibility is discussed that the etiology of the acousticovestibular symptoms in this patient could be an inner ear thromboembolic disorder. It is suggested that platelet functions and fibrinolytic activity should be investigated in patients with acoustico-vestibular symptoms and PAN or other systemic diseases. If abnormalities are found, specific platelet inhibitory and/or fibrinolysis-increasing treatment should be considered as an addition to the conventional medical treatment.
References
Andersen LA, Gormsen J (1976) Platelet aggregation and fibrinolytic activity in transient cerebral ischemia. Acta Neurol Scand 55: 76–82
Bick RL (1980) Disseminated intravascular coagulation (DIC) and related syndromes. In: Murano G, Bick RL (eds) Basic concepts of haemostatsis and thrombosis. CRC Press, New York, pp 164–167
Brozovic M (1977) Physiological mechanisms in coagulation and fibrinolysis. Br Med Bull 33: 231–238
Chignard M, Le Couedic JP, Tencé M, Benveniste J, Vargaftig BB (1979) Platelets release a new mediator, platelet-activating factor, which accounts for ADP and thromboxane-independent aggregation. Thromb Haemostas 42: 246
Cogan DG (1945) Syndrome of nonsyphilitic interstitial keratitis and vestibuloauditory symptoms. Arch Ophthalmol 33: 144–149
Crawford WJ (1957) Cogan's syndrome associated with polyarteritis nodosa. Pa Med 60: 835–838
Edström S, Vahlne A (1976) Immunological findings in a case of Cogan's syndrome. Acta Otolaryngol (Stockh) 82: 212–215
Fischer ER, Hellström HR (1961) Cogan's syndrome and systemic vascular disease. Arch Pathol Lab Med 72: 572–592
Gussen R (1977) Polyarteritis nodosa and deafness. A human temporal bone study. Arch Otorhinolaryngol 217: 263–268
Harker LA, Slichter SJ (1972) Platelet and fibrinogen consumption in man. N Engl J Med 287: 999–1005
Leib ES, Restivo C, Paulus HE (1979) Immunosuppressive and corticosteroid therapy of polyarteritis nodosa. Am J Med 67: 941–947
Lüscher ER, Pfueller LS (1978) Platelets as target of immunological reactions. In: Gaetano G, Goretti S (eds) Platelets, a multidisciplinary approach. Raven Press, New York, pp 261–268
Peitersen E, Carlsen BH (1966) Hearing impairment as the initial sign of polyarteritis nodosa. Acta Otolaryngol (Stockh) 61: 189–195
Wolff D, Bernhard WG, Tsutsumi S, Ross IS, Nussbaum HE (1965) The pathology of Cogan's syndrome causing profound deafness. Ann Otol Rhinol Laryngol 74: 507–520
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bomholt, A., Bjerre Knudsen, J., Permin, H. et al. Profound sensorineural hearing loss in polyarteritis nodosa. Arch Otorhinolaryngol 236, 53–58 (1982). https://doi.org/10.1007/BF00464057
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00464057